You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR EXCEDRIN (MIGRAINE RELIEF)

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for EXCEDRIN (MIGRAINE RELIEF)

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01629329 ↗	Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine	Terminated	Albert Einstein Healthcare Network	Phase 4	2010-11-01	The objective of this randomized, double blind study is to demonstrate that one dose oral "excedrin migraine" (acetaminophen, aspirin and caffeine) is not inferior when compared to one dose of intravenous prochlorperazine for the treatment of acute migraine headaches in the emergency department.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for EXCEDRIN (MIGRAINE RELIEF)

Condition Name

Chart
Table

Condition Name for EXCEDRIN (MIGRAINE RELIEF)
Intervention	Trials
Migraine Headaches	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for EXCEDRIN (MIGRAINE RELIEF)
Intervention	Trials
Migraine Disorders	1
Headache	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for EXCEDRIN (MIGRAINE RELIEF)

Trials by Country

Map
Table

Trials by Country for EXCEDRIN (MIGRAINE RELIEF)
Location	Trials
United States	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for EXCEDRIN (MIGRAINE RELIEF)
Location	Trials
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for EXCEDRIN (MIGRAINE RELIEF)

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for EXCEDRIN (MIGRAINE RELIEF)
Clinical Trial Phase	Trials
Phase 4	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for EXCEDRIN (MIGRAINE RELIEF)
Clinical Trial Phase	Trials
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EXCEDRIN (MIGRAINE RELIEF)

Sponsor Name

Chart
Table

Sponsor Name for EXCEDRIN (MIGRAINE RELIEF)
Sponsor	Trials
Albert Einstein Healthcare Network	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for EXCEDRIN (MIGRAINE RELIEF)
Sponsor	Trials
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.